26 September 2025
Cancers | Notable Papers in the Field of Blood Cancer


As all the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our notable papers in the field of blood cancer, which are listed below:

“Venetoclax Resistance in Acute Myeloid Leukemia”
by Sylvain Garciaz, Marie-Anne Hospital, Yves Collette and Norbert Vey
Cancers 2024, 16(6), 1091; https://doi.org/10.3390/cancers16061091
Available online: https://www.mdpi.com/2072-6694/16/6/1091

“Treatment of Pediatric Acute Lymphoblastic Leukemia: A Historical Perspective”
by Hiroshi Hayashi, Atsushi Makimoto and Yuki Yuza
Cancers 2024, 16(4), 723; https://doi.org/10.3390/cancers16040723
Available online: https://www.mdpi.com/2072-6694/16/4/723

“JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature”
by Seyed Mohammad Vahabi, Saeed Bahramian, Farzad Esmaeili, Bardia Danaei, Yasamin Kalantari, Patrick Fazeli, Sara Sadeghi, Nima Hajizadeh, Chalid Assaf and Ifa Etesami
Cancers 2024, 16(5), 861; https://doi.org/10.3390/cancers16050861
Available online: https://www.mdpi.com/2072-6694/16/5/861

“Evaluating Outcome Prediction via Baseline, End-of-Treatment, and Delta Radiomics on PET-CT Images of Primary Mediastinal Large B-Cell Lymphoma”
by Fereshteh Yousefirizi, Claire Gowdy, Ivan S. Klyuzhin, Maziar Sabouri, Petter Tonseth, Anna R. Hayden, Donald Wilson, Laurie H. Sehn, David W. Scott, Christian Steidl et al.
Cancers 2024, 16(6), 1090; https://doi.org/10.3390/cancers16061090
Available online: https://www.mdpi.com/2072-6694/16/6/1090

“Large Granular Lymphocytic Leukemia: Clinical Features, Molecular Pathogenesis, Diagnosis and Treatment”
by Fauzia Ullah, Mariam Markouli, Mark Orland, Olisaemeka Ogbue, Danai Dima, Najiullah Omar and Moaath K. Mustafa Ali
Cancers 2024, 16(7), 1307; https://doi.org/10.3390/cancers16071307
Available online: https://www.mdpi.com/2072-6694/16/7/1307

“Adverse In-Hospital Outcomes after Radical Prostatectomy in Leukemia History Patients”
by Fabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, Mattia Longoni, Andrea Marmiroli, Quynh Chi Le, Zhe Tian, Jordan A. Goyal, Nicola Longo, Salvatore Micali et al.
Cancers 2024, 16(15), 2764; https://doi.org/10.3390/cancers16152764
Available online: https://www.mdpi.com/2072-6694/16/15/2764

“Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas”
by Francesco D’Alò, Silvia Bellesi, Elena Maiolo, Eleonora Alma, Flaminia Bellisario, Rosalia Malafronte, Marcello Viscovo, Fabrizia Campana and Stefan Hohaus
Cancers 2024, 16(12), 2243; https://doi.org/10.3390/cancers16122243
Available online: https://www.mdpi.com/2072-6694/16/12/2243

“Chimeric Antigen Receptor (CAR) T-Cell Therapy in Hematologic Malignancies: Clinical Implications and Limitations”
by Philipp Blüm and Sabine Kayser
Cancers 2024, 16(8), 1599; https://doi.org/10.3390/cancers16081599
Available online: https://www.mdpi.com/2072-6694/16/8/1599

“Enhancing Lymphoma Diagnosis, Treatment, and Follow-Up Using 18F-FDG PET/CT Imaging: Contribution of Artificial Intelligence and Radiomics Analysis”
by Setareh Hasanabadi, Seyed Mahmud Reza Aghamiri, Ahmad Ali Abin, Hamid Abdollahi, Hossein Arabi and Habib Zaidi
Cancers 2024, 16(20), 3511; https://doi.org/10.3390/cancers16203511
Available online: https://www.mdpi.com/2072-6694/16/20/3511

“T-Cell Engagers—The Structure and Functional Principle and Application in Hematological Malignancies”
by Paweł Cech, Katarzyna Skórka, Laura Dziki and Krzysztof Giannopoulos
Cancers 2024, 16(8), 1580; https://doi.org/10.3390/cancers16081580
Available online: https://www.mdpi.com/2072-6694/16/8/1580

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office

Back to TopTop